|Bid||0.00 x 800|
|Ask||78.90 x 900|
|Day's range||55.05 - 61.43|
|52-week range||5.86 - 82.75|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||25 Mar 2020 - 29 Mar 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||90.21|
Wall Street is littered with unicorns this past year that have been less than magical for investors. These startups that were valued at over a billion dollars in the private market, couldn’t quite live up to lofty expectations when they finally hit the public market. AdvisorShares’ CEO Noah Hamman tells Yahoo Finance that he’s focused on building a portfolio of potential unicorns outside of the high flying names, such as the recent initial public offering of Casper (CSPR). “We are looking for small and micro-cap stocks, which can provide a similar risk return profit as private equity,” says Hamman. “We think it’s a significant area that’s overlooked by investors.”
Kodiak Sciences Inc. (KOD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
The Zacks Analyst Blog Highlights: Microsoft, Kodiak Sciences, General Motors and Procter & Gamble
Kodiak Sciences, Microsoft, and General Motors are on Wall Street's radar right now. Should they be on yours as well?